Barr Pharmaceuticals has announced the launch of the generic version of the company's proprietary Seasonale extended-cycle oral contraceptive under the tradename Jolessa. This oral contraceptive is indicated for the prevention of pregnancy and allows patients to reduce the number of periods from monthly to four per year.

For more information call (800) Barr Lab or visit www.barrlabs.com.